John Peter Mclaughlin

John Peter Mclaughlin has filed trades across 5 companies (mainly through SEC (Form 4)), most often in PDL Biopharma, Inc., Rockwell Medical, Inc. and LENSAR, Inc. The record holds 17 filings, for trades running from 26 January 2016 to 25 May 2023.

Sales make up the whole of the open-market record (2 sales, €700k). The rest of the record consists of 11 share grants.

On 30 May 2023 came the latest disclosure, a share grant in LENSAR, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.